Richard A. Miller M.D. is CEO & President at Corvus Pharmaceuticals, Inc. (CRVS). They have made 26 open-market trades across 2 companies since 2007, most recently 2026-05-18.
CIK 0001031847
26 open-market purchases totalling $4.9M since 2007, never a sale. Across 24 scored buys the stock is up 2.5% at ninety days, and 0.2 points ahead of the S&P over the same stretch.
24 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| CRVS | 1,195,035 | $11.4M |
| PCYC | 295,130 | — |
| Total | $11.4M |
Shares reported on the most recent Form 4, priced at the 2026-05-20 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 54% | 71% | 50% |
| Avg Move | +2.8% | +15.0% | +2.5% |
| Alpha | +3.4% | +14.3% | +0.2% |
| Scored | 24 | 24 | 24 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CRVS | BUY | 2026-05-18 | 2026-05-20 | $12.04 | $83K | -4.5% | +2.9% | +21.3% |
| CRVS | BUY | 2024-05-06 | 2024-05-07 | $1.73 | $2.0M | +22.5% | +12.3% | +50.8% |
| CRVS | BUY | 2022-12-13 | 2022-12-15 | $0.75 | $45K | -4.1% | +7.9% | -12.2% |
| CRVS | BUY | 2022-09-28 | 2022-09-28 | $0.76 | $19K | +17.5% | +10.8% | -1.6% |
| CRVS | BUY | 2022-09-20 | 2022-09-20 | $0.81 | $16K | +3.4% | +15.0% | +2.3% |
| CRVS | BUY | 2022-06-24 | 2022-06-28 | $1.02 | $10K | +8.8% | -12.6% | -29.0% |
| CRVS | BUY | 2022-06-02 | 2022-06-06 | $0.98 | $6K | -9.5% | +2.9% | -13.3% |
| CRVS | BUY | 2022-03-31 | 2022-04-01 | $1.64 | $25K | -19.0% | -26.1% | -46.2% |
| CRVS | BUY | 2022-03-15 | 2022-03-17 | $1.49 | $45K | -6.9% | -23.0% | -43.1% |
| CRVS | BUY | 2021-08-20 | 2021-08-23 | $1.93 | $19K | +30.8% | +260.1% | +56.7% |
| CRVS | BUY | 2021-05-04 | 2021-05-05 | $2.80 | $200K | -17.0% | -10.3% | -30.0% |
| CRVS | BUY | 2021-02-17 | 2021-02-17 | $3.50 | $350K | -8.6% | -17.0% | -30.3% |
| CRVS | BUY | 2019-11-12 | 2019-11-14 | $3.00 | $45K | +1.7% | +27.9% | +60.6% |
| CRVS | BUY | 2019-08-06 | 2019-08-08 | $3.57 | $27K | +9.1% | +3.2% | +1.9% |
| CRVS | BUY | 2019-06-13 | 2019-06-17 | $3.40 | $41K | -8.1% | +47.2% | -2.7% |
| CRVS | BUY | 2019-06-07 | 2019-06-11 | $3.49 | $53K | -3.4% | +57.5% | +11.2% |
| CRVS | BUY | 2018-12-27 | 2018-12-31 | $3.29 | $66K | +19.6% | +7.4% | +10.2% |
| CRVS | BUY | 2018-12-20 | 2018-12-26 | $4.40 | $44K | +41.1% | +18.8% | +20.2% |
| CRVS | BUY | 2018-12-06 | 2018-12-10 | $5.99 | $30K | -27.0% | -26.7% | -24.6% |
| CRVS | BUY | 2018-12-04 | 2018-12-06 | $5.95 | $9K | -19.6% | -24.9% | -28.5% |
| CRVS | BUY | 2018-03-12 | 2018-03-12 | $8.50 | $850K | +7.7% | +10.4% | +29.1% |
| CRVS | BUY | 2017-11-20 | 2017-11-22 | $10.79 | $216K | +5.0% | +0.7% | -23.1% |
| CRVS | BUY | 2017-06-09 | 2017-06-13 | $9.86 | $357K | +6.4% | +14.9% | +61.0% |
| CRVS | BUY | 2016-05-12 | 2016-05-16 | $10.00 | $303K | +21.3% | +0.4% | +19.5% |
| PCYC | BUY | 2007-08-22 | 2007-08-22 | $2.00 | $10K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.